Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1Neoplasm Metastasis 1Digestive System Neoplasms 1Cholangiocarcinoma 1Biliary Tract Neoplasms 1Adenocarcinoma 1

Interventions

Bevacizumab 5Leucovorin 4Irinotecan 4Fluorouracil 4Gemcitabine 3Capecitabine 3napabucasin 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2linifanib 1encorafenib 1apatinib 1Sorafenib 1Polyamines 1Oxaliplatin 1Oviposition 1NUC-1031 1Levoleucovorin 1Everolimus 1Drug Therapy 1Drainage 1Cisplatin 1Cetuximab 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Digestive System Neoplasms × NUC-1031 × Clear all
NCT04163900 2023-05-24

Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer

NuCana plc

Phase 3 Terminated
773 enrolled 15 charts
Gastrointestinal

Adenocarcinoma, Biliary Tract Neoplasms, Digestive System Neoplasms, Neoplasm Metastasis, Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡